These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5175985)

  • 1. Polarizing solutions and intrathecal methylprednisolone acetate in therapy of multiple sclerosis: preliminary study.
    De Vito SJ; Mannarelli AA
    J Am Osteopath Assoc; 1966 Mar; 65(7):713-22. PubMed ID: 5175985
    [No Abstract]   [Full Text] [Related]  

  • 2. Polarizing solution and intrathecal methylprednisolone acetate in multiple sclerosis: follow-up study.
    Beck RH
    J Am Osteopath Assoc; 1967 Feb; 66(6):664-6. PubMed ID: 5182604
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multiple sclerosis. Clinico-statistical results of therapy based on intrathecal methylprednisolone acetate].
    Sbarbaro V; Girelli Bruni E; Monaco V; Gasperini GF; Zardini GB; Brogi L
    Minerva Med; 1974 Sep; 65(65):3407-11. PubMed ID: 4479023
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrathecal methylprednisolone acetate in multiple sclerosis treatment. Clinical evaluation.
    Mazzarello P; Poloni M; Piccolo G; Cosi V; Pinelli P
    Acta Neurol Belg; 1983; 83(4):190-6. PubMed ID: 6689244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Our experiences in the treatment of multiple sclerosis by intrathecal administration of methylprednisolone acetate and follow-up of the cerebrospinal fluid changes during this treatment].
    Jedlicka P; Kupka J; Kocinová F
    Cesk Neurol Neurochir; 1975 Dec; 38(6):338-45. PubMed ID: 1104205
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methylprednisolone acetate in intrathecal administration in multiple sclerosis].
    Palchetti R; Giunta A; Tortoli V; Scarpelli PT
    Rass Neurol Veg; 1965 Jun; 19(3):243-8. PubMed ID: 5899668
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lumbar intrathecal injection of methylprednisolone acetate in the treatment of multiple sclerosis].
    Delzanno GB; Jann G
    Clin Ter; 1969 Jan; 48(2):151-5. PubMed ID: 5409031
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. I. Clinical results].
    Hanák L; Zouhar A
    Cesk Neurol Neurochir; 1974 Sep; 37(5):287-92. PubMed ID: 4479028
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis.
    Goldstein NP; McGuckin WF; McKenzie BF; Mattox VR
    Trans Am Neurol Assoc; 1970; 95():243-4. PubMed ID: 5537958
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrathecal methylprednisolone for multiple sclerosis: evaluation by a standard neurological rating.
    Baker AG
    Ann Allergy; 1967 Dec; 25(12):665-72. PubMed ID: 6072742
    [No Abstract]   [Full Text] [Related]  

  • 11. Complications from methylprednisolone acetate (Depo-Medrol) when injected into the orbit, subarachnoid, or subdural spaces.
    Abel R; Nelson DA; Bernat JL
    Del Med J; 1977 Jun; 49(6):331-43. PubMed ID: 577483
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of multiple sclerosis with intrathecally administered methylprednisolone acetate.
    Ringer WA
    J Indiana State Med Assoc; 1968 Sep; 61(9):1213-5. PubMed ID: 5695699
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. II. Results in cerebrospinal fluid].
    Hrazdira CL; Mandzjuk B; Skálová M
    Cesk Neurol Neurochir; 1974 Sep; 37(5):293-300. PubMed ID: 4479029
    [No Abstract]   [Full Text] [Related]  

  • 14. [Considerations on intrathecal administration of corticosteroids in case of multiple sclerosis].
    Cendrowski W
    Wiad Lek; 1976 Feb; 29(3):193-6. PubMed ID: 946336
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylprednisolone treatment, immune activation, and intrathecal inflammation in multiple sclerosis.
    Sellebjerg F
    Dan Med Bull; 2004 May; 51(2):167-83. PubMed ID: 16009055
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcification and ossification of the spinal arachnoid after intrathecal administration of Depo-Medrol.
    Carta F; Canu C; Datti R; Guiducci G; Pisani R; Silvestro C
    Zentralbl Neurochir; 1987; 48(3):256-61. PubMed ID: 3124393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of the multiple sclerosis patient.
    Boines GJ
    Behav Neuropsychiatry; 1969 Jun; 1(3):29-32. PubMed ID: 5408861
    [No Abstract]   [Full Text] [Related]  

  • 18. [4 cases of influenzal meningo-encephalitis treated with intrathecal methylprednisolone acetate].
    Delzanno GB; Jann G
    Clin Ter; 1969 Aug; 50(4):357-61. PubMed ID: 5395993
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrathecal methylprednisolone acetate in multiple sclerosis treatment: effect on the blood-CSF barrier and on the intrathecal IgG production.
    Rocchelli B; Poloni M; Mazzarello P; Piccolo G; Delodovici M; Pinelli P
    Ital J Neurol Sci; 1982 Jul; 3(2):119-26. PubMed ID: 6896866
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of pulse therapy on delayed contrast-enhancing CT scan lesion in a patient with multiple sclerosis].
    Konishi T; Saida T; Nishitani H
    Rinsho Shinkeigaku; 1986 Jan; 26(1):71-5. PubMed ID: 3698407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.